Jacob Corn is the Scientific Director of the Innovative Genomics Initiative and a University of California, Berkeley faculty member in the department of Molecular and Cell Biology. Corn previously worked at Genentech in the department of Early Discovery Biochemistry, interrogating the feasibility for challenging therapeutic pathways in neurobiology, infectious disease, and oncology. Corn’s current research investigates how biophysical properties interact within the cellular environment to shape signaling behavior, and how disease arises when these properties go awry. At the Innovative Genomics Initiative, Corn seeks to push the boundaries of genome editing in order to improve insight into fundamental biology, and to lay the groundwork for clinical and commercial applications.